Tagami N, Yuda J, Goto Y
Int J Clin Oncol. 2024; 29(11):1676-1683.
PMID: 39222149
PMC: 11511695.
DOI: 10.1007/s10147-024-02611-2.
Stohl W, Wu Y, Stohl M
ACR Open Rheumatol. 2024; 6(11):756-768.
PMID: 39143363
PMC: 11557988.
DOI: 10.1002/acr2.11712.
Deng X, Ge T, Shen K, Wang J, Mu W, Luo H
Blood Sci. 2024; 6(1):e00180.
PMID: 38226020
PMC: 10789450.
DOI: 10.1097/BS9.0000000000000180.
Steele H, Cheng J, Willicut A, Dell G, Breckenridge J, Culberson E
Front Immunol. 2023; 14:1219907.
PMID: 37465675
PMC: 10351606.
DOI: 10.3389/fimmu.2023.1219907.
Garcia-Carmona Y, Fribourg M, Sowa A, Cerutti A, Cunningham-Rundles C
Clin Immunol. 2023; 253:109689.
PMID: 37422057
PMC: 10528899.
DOI: 10.1016/j.clim.2023.109689.
The BAFF-APRIL System in Cancer.
Ullah M, Mackay F
Cancers (Basel). 2023; 15(6).
PMID: 36980677
PMC: 10046288.
DOI: 10.3390/cancers15061791.
The intestine: A highly dynamic microenvironment for IgA plasma cells.
Pracht K, Wittner J, Kagerer F, Jack H, Schuh W
Front Immunol. 2023; 14:1114348.
PMID: 36875083
PMC: 9977823.
DOI: 10.3389/fimmu.2023.1114348.
Aberrant B Cell Signaling in Autoimmune Diseases.
Corneth O, Neys S, Hendriks R
Cells. 2022; 11(21).
PMID: 36359789
PMC: 9654300.
DOI: 10.3390/cells11213391.
TNFRSF13B in B cell responses to organ transplantation.
Cascalho M, Platt J
Hum Immunol. 2022; 84(1):27-33.
PMID: 36333165
PMC: 10429825.
DOI: 10.1016/j.humimm.2022.09.006.
APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant model.
Bath N, Verhoven B, Wilson N, Zeng W, Zhong W, Coons L
PLoS One. 2022; 17(10):e0275564.
PMID: 36227902
PMC: 9562156.
DOI: 10.1371/journal.pone.0275564.
B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages.
Teymouri Nobari S, Nouri Nojadeh J, Talebi M
J Transl Med. 2022; 20(1):82.
PMID: 35144648
PMC: 8832753.
DOI: 10.1186/s12967-022-03285-y.
TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells.
de Mattos Barbosa M, Lefferts A, Huynh D, Liu H, Zhang Y, Fu B
JCI Insight. 2021; 6(17).
PMID: 34283811
PMC: 8492324.
DOI: 10.1172/jci.insight.150483.
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression.
Hinterleitner C, Zhou Y, Tandler C, Heitmann J, Kropp K, Hinterleitner M
Front Oncol. 2021; 11:642170.
PMID: 33816291
PMC: 8010255.
DOI: 10.3389/fonc.2021.642170.
Diversification Fueled by B Cell Responses to Environmental Challenges-A Hypothesis.
Cascalho M, Platt J
Front Immunol. 2021; 12:634544.
PMID: 33679786
PMC: 7925820.
DOI: 10.3389/fimmu.2021.634544.
B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease.
Matson E, Abyazi M, Bell K, Hayes K, Maglione P
Front Immunol. 2021; 11:622114.
PMID: 33613556
PMC: 7892472.
DOI: 10.3389/fimmu.2020.622114.
TACI Constrains T17 Pathogenicity and Protects against Gut Inflammation.
Tan A, Tso G, Zhang B, Teo P, Ou X, Ng S
iScience. 2020; 23(11):101707.
PMID: 33205021
PMC: 7653077.
DOI: 10.1016/j.isci.2020.101707.
Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells.
Grasset E, Chorny A, Casas-Recasens S, Gutzeit C, Bongers G, Thomsen I
Sci Immunol. 2020; 5(49).
PMID: 32737068
PMC: 8349226.
DOI: 10.1126/sciimmunol.aat7117.
Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents.
Wise L, Stohl W
Front Med (Lausanne). 2020; 7:303.
PMID: 32695790
PMC: 7338653.
DOI: 10.3389/fmed.2020.00303.
Characterization and high-yield production of non--glycosylated recombinant human BCMA-Fc in .
Hou W, Meng X, Wang Y, Mo W, Wu Y, Yu M
Eng Life Sci. 2020; 17(2):96-106.
PMID: 32624756
PMC: 6999299.
DOI: 10.1002/elsc.201600039.
Transmembrane Activator and CAML Interactor (TACI): Another Potential Target for Immunotherapy of Multiple Myeloma?.
Xu S, Lam K
Cancers (Basel). 2020; 12(4).
PMID: 32340409
PMC: 7226350.
DOI: 10.3390/cancers12041045.